** BMO Capital Markets downgrades rating on chemical company Dow DOW.N to "underperform" from "market perform", lowers PT to $22 from $29
** New PT represents a 20.7% downside to the stock's last close
** Brokerage says weakness across its end-markets is resulting in soft pricing and lower volumes/operating rates, which will likely result in severely challenged Q2 EBITDA and 2H estimates coming solidly lower
** "With no end in sight for these anemic earnings levels, there appears a heightened risk DOW may cut the dividend," - BMO adds
** 3 of 22 brokerages rate the stock "buy" or higher, 16 "hold" and 3 "sell" or lower; median PT is $32 - data compiled by LSEG
** Up till last close, stock down 30.8% YTD
(Reporting by Pooja Menon in Bengaluru)
((Pooja.Menon@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。